Madame Bioscience PCL (BKK:MADAME) Total Operating Expense: ฿472 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:MADAME Madame Bioscience PCL BKK:MADAME
21 GF Score
Price ฿0.62
GF Value ฿0.64
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Madame Bioscience PCL Total Operating Expense?

Madame Bioscience PCL BKK:MADAME -3.13% 21 Total Operating Expense is ฿472 Mil as of Mar. 2026. GuruFocus rates BKK:MADAME with a GF Score™ of 21/100 and a GF Value™ of ฿0.64 (Fairly Valued). The stock has 2 warning signs investors should review.

Madame Bioscience PCL's Total Operating Expense for the three months ended in Mar. 2026 was ฿94 Mil. Madame Bioscience PCL's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ฿472 Mil.

Madame Bioscience PCL Total Operating Expense Related Terms

Madame Bioscience PCL Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Madame Bioscience PCL's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Madame Bioscience PCL Total Operating Expense Chart

Madame Bioscience PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 417.41 501.11 476.88 332.59 531.42

Madame Bioscience PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 153.92 91.16 109.38 177.37 94.10
BKK:MADAME
21GF Score
Madame Bioscience PCL BKK:MADAME
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Madame Bioscience PCL Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ฿472 Mil mean?
Madame Bioscience PCL (BKK:MADAME) has a Total Operating Expense of ฿472 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Madame Bioscience PCL and its competitors.
Is Madame Bioscience PCL's Total Operating Expense too high?
Madame Bioscience PCL's current Total Operating Expense is ฿472 Mil. Overall, Madame Bioscience PCL has a GF Score™ of 21/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Madame Bioscience PCL's Total Operating Expense compare to KHC and GIS?
Madame Bioscience PCL's Total Operating Expense of ฿472 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Consumer Packaged Goods company?
A good Total Operating Expense depends on the Consumer Packaged Goods industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Madame Bioscience PCL and its competitors. Madame Bioscience PCL's current Total Operating Expense is ฿472 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madame Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, Madame Bioscience PCL (BKK:MADAME) is currently considered Fairly Valued. The stock's GF Value™ is ฿0.64, compared to a current price of ฿0.62 — trading 3.1% below its estimated fair value. The current Total Operating Expense is ฿472 Mil. Madame Bioscience PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Madame Bioscience PCL (BKK:MADAME), the current Total Operating Expense is ฿472 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Madame Bioscience PCL (BKK:MADAME) Overvalued in 2026?

Based on GuruFocus' analysis, Madame Bioscience PCL stock appears to be undervalued. The current stock price of ฿0.62 is trading 3.1% below its estimated GF Value™ of ฿0.64. GuruFocus considers Madame Bioscience PCL to be Fairly Valued.

Key valuation signals for BKK:MADAME:

  • Total Operating Expense: ฿472 Mil
  • GF Value™: ฿0.64 vs. price of ฿0.62 (3.1% below fair value)
  • GF Score™: 21/100 with 2 warning signs

No single metric tells the full story. See the BKK:MADAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Madame Bioscience PCL Business Description

Address Praditmanutham Road, 60, 2nd Floor, Soi Praditmanutham 19, Lat Phrao, Lat Phrao, Bangkok, THA, 10230
Madame Bioscience PCL is engaged in the segments of the Packaging business, Food business, Retail sales of cosmetics, and Other businesses. Its activities include the manufacturing and selling of plastic packaging, restaurant business, advertising rental service in the gas station and manufacturing and selling of dried fruits, among others. The group derives a majority of its revenue from the Food business. The firm's product portfolio includes Ready meals, Frozen food, value-added seafood and vegetables, Flexible packaging, and PET Bottles.
21GF Score

Get the complete analysis for BKK:MADAME

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.62
Price
฿0.64
GF Value